GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R109. A total of 8 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,000 | -66.7% | 11,100 | 0.0% | 0.01% | -86.7% |
| Q2 2014 | $12,000 | -25.0% | 11,100 | 0.0% | 0.10% | +206.2% |
| Q1 2014 | $16,000 | 0.0% | 11,100 | 0.0% | 0.03% | -57.9% |
| Q4 2013 | $16,000 | -67.3% | 11,100 | -47.4% | 0.08% | -58.7% |
| Q3 2013 | $49,000 | +113.0% | 21,100 | +108.9% | 0.18% | +2528.6% |
| Q2 2013 | $23,000 | – | 10,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 73,744 | $42,000 | 0.00% |
| A.R.T. Advisors, LLC | 13,100 | $7,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 14,652 | $8,000 | 0.00% |
| MORGAN STANLEY | 16 | $0 | 0.00% |
| Citadel Advisors | 14,777 | $8,000 | 0.00% |
| Renaissance Technologies | 108,800 | $62,000 | 0.00% |
| JANE STREET GROUP, LLC | 14,715 | $8,000 | 0.00% |
| UBS AG | 3,000 | $2,000 | 0.00% |